0001104659-24-032999.txt : 20240311 0001104659-24-032999.hdr.sgml : 20240311 20240311162212 ACCESSION NUMBER: 0001104659-24-032999 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240311 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHPEAK PROPERTIES, INC. CENTRAL INDEX KEY: 0000765880 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 330091377 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08895 FILM NUMBER: 24738329 BUSINESS ADDRESS: STREET 1: 4600 SOUTH SYRACUSE STREET STREET 2: SUITE 500 CITY: DENVER STATE: CO ZIP: 80237 BUSINESS PHONE: 949-407-0700 MAIL ADDRESS: STREET 1: 4600 SOUTH SYRACUSE STREET STREET 2: SUITE 500 CITY: DENVER STATE: CO ZIP: 80237 FORMER COMPANY: FORMER CONFORMED NAME: HCP, INC. DATE OF NAME CHANGE: 20070911 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH CARE PROPERTY INVESTORS INC DATE OF NAME CHANGE: 19920703 8-K 1 tm248304d1_8k.htm FORM 8-K
false 0000765880 0000765880 2024-03-11 2024-03-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K 

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 11, 2024

 

 

 

Healthpeak Properties, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland 001-08895 33-0091377
(State or other jurisdiction of incorporation) (Commission File Number)

(IRS Employer Identification No.)

 

4600 South Syracuse Street, Suite 500

Denver, CO 80237

(Address of principal executive offices, including zip code)

 

(720) 428-5050

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report.)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
     
Common stock, $1.00 par value DOC New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01Entry Into a Material Definitive Agreement

 

On March 11, 2024, Healthpeak Properties, Inc., a Maryland corporation (the “Company”), and Healthpeak OP, LLC, a Maryland limited liability company (the “operating company”), entered into an amendment (the “Amendment”) to the “at-the market” equity offering sales agreement (the “Sales Agreement”) with each of J.P. Morgan Securities LLC, Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, each as sales agent and principal (except in the case of Nomura Securities International, Inc.) and forward seller (except in the case of BTIG, LLC and Capital One Securities, Inc.), from time to time (in such capacity, each an “Agent” and, collectively, the “Agents”) in each case as described below, and the Forward Purchasers (as defined below), relating to (i) the issuance and sale by the Company to or through the Sales Agents, from time to time, of shares (the “Issuance Shares”) of the Company’s common stock, par value $1.00 per share (“Common Stock”), and (ii) the sale by the Forward Sellers, as agents on behalf of the Forward Purchasers, of Common Stock (together with the Issuance Shares, the “Securities”). We refer to these entities, when acting in their capacity as sales agents for the Company, individually as a “Sales Agent” and collectively as the “Sales Agents,” when acting in their capacity as counterparties to forward sale agreements, individually as a “Forward Purchaser” and collectively as the “Forward Purchasers,” and when acting in their capacity as agents for the Forward Purchasers, individually as a “Forward Seller” and collectively as the “Forward Sellers.”

 

The purpose of the Amendment was to contemplate the sales of the remaining shares of Common Stock pursuant to the Sales Agreement pursuant to the Company’s new Registration Statement on Form S-3 (Registration Nos. 333-276954 and 333-276954-01) filed with the Securities and Exchange Commission (the “SEC”) on February 8, 2024. Pursuant to the Sales Agreement, shares of the Common Stock having an aggregate gross sales price of up to $1,500,000,000 may be offered and sold from time to time. No shares of the Company’s common stock have been offered and sold under the Sales Agreement as of the date hereof, therefore shares of the Company’s Common Stock having an aggregate gross sales price of up to $1,500,000,000 are available for offer and sale under the Sales Agreement. The foregoing description of the Amendment is qualified in its entirety by reference to the Amendment filed as Exhibit 1.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

In connection with the Amendment, the Company filed with the SEC a prospectus supplement (the “ATM Prospectus Supplement”), dated March 11, 2024, to its shelf registration statement on Form S-3 (Registration Nos. 333-276954 and 333-276954 -01), which was filed with the SEC and became effective on February 8, 2024, pursuant to Rule 424(b) under the Securities Act of 1933, as amended.

 

The Company is filing this Current Report on Form 8-K to provide the legal opinion of its counsel, Ballard Spahr LLP, regarding the legality of the Securities to be issued by the Company and covered by the ATM Prospectus Supplement, which opinion is attached hereto as Exhibit 5.1.

 

Item 9.01Financial Statements and Exhibits.

 

(d) Exhibits.

 

  No.   Description
  1.1   Amendment No. 1 to At-the-Market Equity Offering Sales Agreement, dated March 11, 2024, among the Company, the operating company, the Sales Agents, the Forward Sellers and the Forward Purchasers
  5.1   Opinion of Ballard Spahr LLP
  23.1   Consent of Ballard Spahr LLP (included in Exhibit 5.1)
  104   The cover page of this Current Report on Form 8-K, formatted in Inline XBRL
       

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Healthpeak Properties, Inc.
     
  By: /s/ Peter A. Scott
  Name: Peter A. Scott
  Title: Chief Financial Officer
      
Date: March 11, 2024    

 

 

 

 

 

 EX-1.1 2 tm248304d1_ex1-1.htm EXHIBIT-1.1

 

 

Exhibit 1.1

 

Healthpeak Properties, Inc.

 

Common Stock

($1.00 par value)

 

AMENDMENT NO. 1 TO AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT

 

March 11, 2024

 

J.P. Morgan Securities LLC

Barclays Capital Inc.

BNP Paribas Securities Corp.

BofA Securities, Inc.

BTIG, LLC

Capital One Securities, Inc.

Credit Agricole Securities (USA) Inc.

Goldman Sachs & Co. LLC

Jefferies LLC

Mizuho Securities USA LLC

Morgan Stanley & Co. LLC

Nomura Securities International, Inc. (as forward seller through BTIG, LLC)

RBC Capital Markets, LLC

Regions Securities LLC

Robert W. Baird & Co. Incorporated

Scotia Capital (USA) Inc.

TD Securities (USA) LLC

Truist Securities, Inc.

Wells Fargo Securities, LLC

 

As Agents

 

JPMorgan Chase Bank, National Association

Bank of America, N.A.

The Bank of Nova Scotia

Barclays Bank PLC

BNP Paribas

Crédit Agricole Corporate and Investment Bank

Goldman Sachs & Co. LLC

Jefferies LLC

Mizuho Markets Americas LLC

Morgan Stanley & Co. LLC

Nomura Global Financial Products, Inc.

 

 

 

 

Regions Securities LLC

Robert W. Baird & Co. Incorporated

Royal Bank of Canada

The Toronto-Dominion Bank

Truist Bank

Wells Fargo Bank, National Association

 

As Forward Purchasers

 

c/o J.P. Morgan Securities LLC
  383 Madison Avenue
  New York, New York 10179

 

Ladies and Gentlemen:

 

Reference is made to that certain At-the-Market Equity Offering Sales Agreement, dated February 17, 2023 (the “Sales Agreement”), among J.P. Morgan Securities LLC, Barclays Capital Inc., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC, Robert W. Baird & Co. Incorporated, Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, each as sales agent, principal and, in certain cases, forward seller (in any such capacity, each, an “Agent”, and collectively, the “Agents”), and JPMorgan Chase Bank, National Association, Bank of America, N.A., The Bank of Nova Scotia, Barclays Bank PLC, Crédit Agricole Corporate and Investment Bank, Credit Suisse International, Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, Regions Securities LLC, Royal Bank of Canada, SMBC Nikko Securities America, Inc., The Toronto-Dominion Bank, Truist Bank and Wells Fargo Bank, National Association, each as forward purchaser (in such capacity, each a “Forward Purchaser”, and collectively, the “Forward Purchasers”) and Healthpeak Properties, Inc., a Maryland corporation (the “Company”), and Healthpeak OP, LLC, a Maryland limited liability company (the “Operating Company”) with respect to the offering and sale from time to time by the Company to or through the Agents, of shares of its common stock, $1.00 par value, having an aggregate gross sales price of up to $1,500,000,000, in the manner and subject to the terms and conditions set forth in the Sales Agreement. All capitalized terms used in this Amendment No. 1 to the Sales Agreement (this “Amendment”) and not otherwise defined herein shall have the respective meanings assigned to such terms in the Sales Agreement. For the avoidance of doubt, all references to the Sales Agreement in any document related to the transactions contemplated by the Sales Agreement shall be to the Sales Agreement as amended by this Amendment. The Agents, the Forward Purchasers, the Company and the Operating Company (collectively, the “parties hereto”) agree as follows:

 

2 

 

 

1.Amendments to Sales Agreement. The parties hereto agree that the Sales Agreement is amended as follows:

 

(a)As contemplated by the Sales Agreement, from and after the date hereof, the term “Registration Statement” as used in the Sales Agreement, shall include the Company’s registration statement on Form S-3 (Nos. 333-276954 and 333-276954-01) filed with the Commission on February 8, 2024; and the term “Base Prospectus,” as used in the Sales Agreement, shall mean the base prospectus included in the Prospectus most recently filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act.

 

(b)All references in the Sales Agreement to “Credit Suisse Securities (USA) LLC,” “Credit Suisse Capital LLC” and “SMBC Nikko Securities America, Inc.” (which entities have elected to terminate the Sales Agreement as to themselves), including their respective names and addresses appearing on pages 1 and 2 of the Sales Agreement, their respective names and addresses for notice appearing in Section 10 of the Sales Agreement and their respective names and signatures appearing on the signature pages of the Sales Agreement, shall be deleted, effective as of March 11, 2024, and effective as of March 11, 2024, neither Credit Suisse Securities (USA) LLC, Credit Suisse Capital LLC nor SMBC Nikko Securities America, Inc. shall be an Agent or Forward Purchaser under the Sales Agreement.

 

(c)As of the date hereof, all references in the Sales Agreement to “JPMorgan Chase Bank, National Association, New York Branch” and “Regions Bank” shall refer to JPMorgan Chase Bank, National Association and Regions Securities LLC, respectively, including their respective names and addresses appearing on page 1 of the Sales Agreement, their respective names and addresses for notice appearing in Section 10 of the Sales Agreement and respective signatures appearing on the signature pages of the Sales Agreement.

 

(d)As of the date hereof, the parties acknowledge and agree that, by virtue of this Amendment, the following entities have joined as parties to the Sales Agreement in the following capacities: (i) BNP Paribas Securities Corp. has joined as an Agent; (ii) BNP Paribas has joined as a Forward Purchaser (iii) Nomura Securities International, Inc. (as forward seller through BTIG, LLC as its agent) has joined as an Agent, solely in its capacity as forward seller; (iv) Nomura Global Financial Products, Inc. has joined as a Forward Purchaser; and (v) Robert W. Baird & Co. Incorporated has joined as a Forward Purchaser. The parties hereto, to the extent required by the Sales Agreement, consent to this Amendment and the transactions contemplated hereby (including the addition of the foregoing entities as parties to the Sales Agreement in their respective capacities).

 

(e)As of the date hereof, the parties acknowledge and agree that, by virtue of this Amendment, the Company shall deliver any instruction or request that borrowed Shares be offered and sold through Nomura Securities International, Inc. to Nomura Securities International, Inc., BTIG, LLC and Nomura Global Financial Products, Inc. Such instruction or request shall only be effective if Nomura Securities International, Inc., BTIG, LLC and Nomura Global Financial Products, Inc. agree to the proposed terms, which any of them may accept, reject or propose new terms in their respective sole discretion.

 

3 

 

 

(f)As of the date hereof, the first full paragraph of the Sales Agreement shall be deleted in its entirety and replaced with the following:

 

“         Healthpeak Properties, Inc., a Maryland corporation (the “Company”) and Healthpeak OP, LLC, a Maryland limited liability company (the “Operating Company”), confirm their agreement with J.P. Morgan Securities LLC, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Nomura Securities International, Inc. (as forward seller through BTIG, LLC as its agent), RBC Capital Markets, LLC, Regions Securities LLC, Robert W. Baird & Co. Incorporated, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, each as sales agent, as principal (except in the case of Nomura Securities International, Inc.) and as forward seller (except in the case of BTIG, LLC) (in any such capacity, each, an “Agent”, and collectively, the “Agents”), and JPMorgan Chase Bank, National Association, Bank of America, N.A., The Bank of Nova Scotia, Barclays Bank PLC, BNP Paribas, Crédit Agricole Corporate and Investment Bank, Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, Nomura Global Financial Products, Inc., Regions Securities LLC, Robert W. Baird & Co. Incorporated, Royal Bank of Canada, The Toronto-Dominion Bank, Truist Bank and Wells Fargo Bank, National Association, each as forward purchaser (in such capacity, each a “Forward Purchaser”, and collectively, the “Forward Purchasers”). For purposes of clarity, it is understood and agreed by the parties hereto that, if Shares (as defined below) are offered or sold through any Agent, as forward seller, then such Agent shall be acting solely in its capacity as sales agent for the applicable Forward Purchaser and not as sales agent for the Company with respect to the offering and sale of such Shares, and, except in cases where this Agreement (as defined below) expressly refers to an Agent acting as sales agent for the Company or unless otherwise expressly stated or the context otherwise requires, references in this Agreement to any Agent acting as sales agent shall also be deemed to apply to such Agent as forward seller, mutatis mutandis, except that Nomura Securities International, Inc. shall only be a forward seller and shall therefore not act as sales agent for the Company. It is also understood and agreed by the parties hereto that, if Shares are offered or sold through any Agent, as sales agent for the Company, then such Agent shall be acting solely in its capacity as sales agent for the Company, and not as sales agent for any Forward Purchaser, with respect to the offering and sale of such Shares. For the avoidance of doubt, BTIG, LLC will not be a forward seller.”

 

4 

 

 

(g)As of the date hereof, Section 10 of the Sales Agreement shall be deleted in its entirety and replaced with the following:

 

“Section 10.   Notices.  Unless otherwise provided herein, all notices required under the terms and provisions hereof shall be in writing, either delivered by hand, by mail, email or by fax, and any such notice shall be effective when received at the address specified below:

 

If to the Company or the Operating Company, to:

 

Healthpeak Properties, Inc.

4600 South Syracuse Street, Suite 500

Denver, Colorado 80237

Attention: Jeffrey H. Miller

Email: jhmiller@healthpeak.com

With cc: DerivativeCompliance@healthpeak.com

 

With a copy (which shall not constitute notice) to:

 

Lewis W. Kneib, Esq.

Latham & Watkins LLP

10250 Constellation Blvd., Suite 1100

Century City, California 90067

Email: lewis.kneib@lw.com

 

If to an Agent or Forward Purchaser, as applicable, delivered via fax or email with a confirmation copy mailed to the addresses set forth below:

 

J.P. Morgan Securities LLC

383 Madison Avenue, 6th Floor

New York, New York 10179

Attention: Sanjeet Dewal

Telephone: (212) 622-8783

Email: sanjeet.s.dewal@jpmorgan.com

 

Morgan Stanley & Co. LLC

1585 Broadway
New York, New York 10036
Attention: Equity Syndicate Desk, with a copy to the Legal Department
Facsimile: 212-507-1554

 

Barclays Capital Inc.

745 Seventh Avenue
New York, New York 10019
Attention: Syndicate Registration

Facsimile: (646) 834-8133

 

Nomura Securities International, Inc.

309 West 49th Street

New York, New York 10019

Attention: Structured Equity Solutions

Email: atmexecution@nomura.com

With a copy (which shall not constitute notice) to:

Attention: Equities Legal

Email: Dan.Rosenbaum@nomura.com

And to:

BTIG, LLC as agent of the forward seller, at the notice addresses provided for BTIG, LLC herein

 

 

5 

 

 

BNP Paribas Securities Corp.

787 Seventh Ave

New York, New York 10019

Attention: Robert McDonald

Phone: (212) 471-6840

Email: dl.nyk.ste@us.bnpparibas.com

RBC Capital Markets, LLC

200 Vesey Street, 8th Floor

New York, New York 10281

Attention: Equity Capital Markets

Facsimile: (212) 428-6260

   

BofA Securities, Inc.

One Bryant Park

New York, New York 10036

Attention: ATM Execution Team,

email: dg.atm_execution@bofa.com

Facsimile: (646) 855-3073

 

Regions Securities LLC
615 South College Street, Suite 600

Charlotte, North Carolina 28202

Email: ECMDesk@regions.com

BTIG, LLC

65 East 55th Street

New York, New York 10022

Attention: ATM Trading Desk

Email: BTIGUSATMTrading@btig.com

with a copy to IBLegal@btig.com;

BTIGcompliance@btig.com; and

ctaylor@btig.com

 

Robert W. Baird & Co. Incorporated

777 E. Wisconsin Avenue

Milwaukee, Wisconsin 53202

Attention: Syndicate Department

Facsimile: (414) 298-7474

With a copy to: Legal Department

 

Capital One Securities, Inc.

201 Charles Ave. Suite 1830

New Orleans, Louisiana 70170

Attention: Phil Winiecki

Email: phil.winiecki@capitalone.com

 

Scotia Capital (USA) Inc.

250 Vesey Street

New York, New York 10281

Attention: Equity Capital Markets

Facsimile: (212) 225-6653

Email: us.ecm@scotiabank.com

us.legal@scotiabank.com

 

Credit Agricole Securities (USA) Inc.

1301 Avenue of the Americas

New York, New York 10019

Attention: Douglas Cheng

Email: douglas.cheng@ca-cib.com;

equitycapitalmarkets@ca-cib.com

Facsimile: (212) 261-2516

 

TD Securities (USA) LLC

1 Vanderbilt Avenue

New York, New York 10017

Attention: Equity Capital Markets

Email: TDS_ATM@tdsecurities.com

Goldman Sachs & Co. LLC

200 West Street

New York, New York 10282-2198

Attention: Registration Department

Truist Securities, Inc.

3333 Peachtree Road NE, 11th Floor

Atlanta, Georgia 30326

Attention: Equity Capital Markets

Email: dl.atm.offering@truist.com

 

 

6 

 

 

Jefferies LLC

520 Madison Avenue

New York, New York 10022

Attention: General Counsel, with a copy to: CorpEqDeriv@jefferies.com

 

Wells Fargo Securities, LLC

500 West 33rd Street

New York, New York 10001

Attention: Equity Syndicate Department

Facsimile: (212) 214-5918

Mizuho Securities USA LLC

1271 Avenue of the Americas

New York, NY 10020

Attention: Stephen Roney; Ivana Rupcic-Hulin; Daniel Blake

Telephone: (212) 205-7527

Email: Stephen.Roney@mizuhogroup.com; Ivana.Rupcic-Hulin@mizuhogroup.com;

Daniel.Blake@mizuhogroup.com, with a copy to: legalnotices@mizuhogroup.com

 

  

and

 

JPMorgan Chase Bank, National Association

383 Madison Avenue

New York, New York 10179

Attention: EDG Marketing Support

Email: edg_notices@jpmorgan.com and edg_ny_corporate_sales_support@jpmorgan.com

With a copy to:

Attention: Sanjeet Dewal

Telephone: (212) 622-8783

Email: sanjeet.s.dewal@jpmorgan.com

 

Mizuho Markets Americas LLC

c/o Mizuho Securities USA LLC, as agent

1271 Avenue of the Americas

New York, NY 10020

Attention: US Equity Derivatives Notices

Telephone: (646) 949-9531

Email: Derivs-EQNoticesUS@mizuhogroup.com

 

Bank of America, N.A.

One Bryant Park

New York, New York 10036

Attention: Rohan Handa

Email: rohan.handa@baml.com

 

 

Morgan Stanley & Co. LLC

1585 Broadway
New York, New York 10036
Attention: Equity Syndicate Desk, with a copy to the Legal Department
Facsimile: 212-507-1554

 

 

7 

 

 

The Bank of Nova Scotia

44 King Street West

Toronto, Ontario, Canada M5H 1H1

c/o Scotia Capital (USA) Inc.

250 Vesey Street, 24th Floor

New York, NY 10281

Attention: US Equity Derivatives

Email: bahar.lorenzo@scotiabank.com / john.kelly@scotiabank.com

Telephone No.: (212) 225-5230 / (212) 225-6664

And a copy to: BNSEquityConfirmations@scotiabank.com

Nomura Global Financial Products, Inc.

309 West 49th Street

New York, New York 10019

Attention: Structured Equity Solutions

Email: cedamericas@nomura.com

With a copy (which shall not constitute notice) to:

Attention: Equities Legal

Email: nyequitieslegal@nomura.com

And to:

BTIG, LLC, at the notice addresses provided for BTIG, LLC herein

 

Barclays Bank PLC

c/o Barclays Capital Inc.

745 Seventh Avenue

New York, New York 10019

Attn: Ilya Blanter

Email: Ilya.Blanter@Barclays.com

 

Regions Securities LLC
615 South College Street, Suite 600

Charlotte, North Carolina 28202

Email: ECMDesk@regions.com

BNP Paribas

787 Seventh Avenue

New York, New York 10019

Robert W. Baird & Co. Incorporated

777 E. Wisconsin Avenue

Milwaukee, Wisconsin 53202

Attention: Syndicate Department

Facsimile: (414) 298-7474

With a copy to: Legal Department

 

Crédit Agricole Corporate and Investment Bank c/o Credit Agricole Securities (USA) Inc., as agent

1301 Avenue of the Americas

New York, New York 10019

Attention: Jonathan Fecowicz

Email: jonathan.fecowicz@ca-cib.com

 

Royal Bank of Canada

200 Vesey Street, 8th Floor

New York, New York 10281

Attention: Equity Capital Markets

Facsimile: (212) 428-6260

 

 

 

8 

 

 

Goldman Sachs & Co. LLC

200 West Street

New York, New York 10282-2198

Attention: Registration Department, with a copy to

Eq-derivs-notifications@am.ibd.gs.com

 

The Toronto-Dominion Bank

c/o TD Securities (USA) LLC, as Agent

1 Vanderbilt Avenue

New York, New York 10017

Attention: Global Equity Derivatives

Phone: (212) 827-7306

Email: TDUSA-GEDUSInvestorSolutionsSales@tdsecurities.com; vanessa.simonetti@tdsecurities.com;

christopher.obalde@tdsecurities.com;

Michael.murphy3@tdsecurities.com; adriano.pierroz@tdsecurities.com

   

Jefferies LLC

520 Madison Avenue

New York, New York 10022

Attention: Strategic Equity Transactions Group, with a copy to: SETG-US@jefferies.com and CorpEqDeriv@jefferies.com

Truist Bank

3333 Peachtree Road NE, 11th Floor

Atlanta, Georgia 30326

Attention: Equity Syndicate Department

Email: dl.atm.offering@truist.com, with a copy to michael.collins@truist.com

 

 

Wells Fargo Bank, National Association

500 West 33rd Street

New York, New York 10001

Attention: Equity Syndicate Department

Facsimile: (212) 214-5918

 

With a copy (which shall not constitute notice) to:

 

Sharon R. Flanagan, Esq.

Sidley Austin LLP
555 California Street, Suite 2000
San Francisco, California 94104-1715
Email: sflanagan@sidley.com

 

and

 

J. Gerard Cummins, Esq.
Sidley Austin LLP
787 Seventh Avenue

New York, New York 10019
Email: jcummins@sidley.com

 

or at such other address as such party may designate from time to time by notice duly given in accordance with the terms of this Section 10.”

 

9 

 

 

(h)As of the date hereof, Annex 1 to the Sales Agreement is hereby deleted in its entirety and replaced with Annex 1 attached hereto.

 

2.Prospectus Supplement. The Company agrees to file promptly with the Commission a supplement to the Prospectus to reflect the fact that Credit Suisse Securities (USA) LLC, Credit Suisse Capital LLC and SMBC Nikko Securities America, Inc. have ceased to be parties under the Sales Agreement and that BNP Paribas Securities Corp, BNP Paribas, Nomura Securities International, Inc. (as forward seller through BTIG, LLC as its agent), Nomura Global Financial Products, Inc. (as Forward Purchaser) and Robert W. Baird & Co. Incorporated (as a Forward Purchaser) have joined as parties to the Sales Agreement, agrees to provide such prospectus supplement to the other parties hereto and Sidley Austin LLP with a reasonable amount of time prior to the proposed filing thereof, and agrees not to file or use such prospectus supplement if any of the other parties hereto or Sidley Austin LLP shall reasonably object thereto. The parties hereto agree that such prospectus supplement shall be deemed to have been filed with the Commission in accordance with Section 3(c) of the Sales Agreement and that the term “Prospectus Supplement,” as used in the Agreement, shall be deemed to include such prospectus supplement.

 

3.No Other Amendments. The parties hereto agree that, except as set forth in, and amended by, Section 1 above, all the terms and provisions of the Sales Agreement shall remain in full force and effect.

 

4.Counterparts and Electronic Signature. This Amendment may be executed by any one or more of the parties hereto in any number of counterparts, each of which shall be deemed to be an original, but all such respective counterparts shall together constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

5.Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and to be performed in such State.

 

[Signature Pages Follow]

 

10 

 

 

If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company and the Operating Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement among the Agents, the Forward Purchasers, the Company and the Operating Company in accordance with its terms.

 

  Very truly yours,
   
  Healthpeak Properties, Inc.
   
  By: /s/ Peter A. Scott
  Name: Peter A. Scott
  Title: Chief Financial Officer
   
  Healthpeak OP, LLC
   
  By: Healthpeak Properties, Inc.,
  its Managing Member
   
  By: /s/ Peter A. Scott
  Name: Peter A. Scott
  Title: Chief Financial Officer

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Accepted as of the date hereof:

 

J.P. Morgan Securities LLC

 

As Agent

 

By: /s/ Brett Chalmers  
  Name: Brett Chalmers  
  Title: Executive Director  

 

JPMorgan Chase Bank, National Association

 

As Forward Purchaser

 

By: /s/ Brett Chalmers  
  Name: Brett Chalmers  
  Title: Executive Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Barclays Capital Inc.

 

As Agent

 

By: /s/ Warren Fixmer  
  Name: Warren Fixmer  
  Title: Managing Director  

 

Barclays Bank PLC

 

As Forward Purchaser

 

By: /s/ Warren Fixmer  
  Name: Warren Fixmer  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

BNP Paribas Securities Corp.

 

As Agent

 

By: /s/ Steve Nawrocki  
 

Name:

Steve Nawrocki

  
  Title: Managing Director  

 

By: /s/ Robert McDonald  
 

Name:

Robert McDonald

  
  Title: Managing Director  

 

BNP Paribas

 

As Forward Purchaser

 

By: /s/ Steve Nawrocki  
 

Name:

Steve Nawrocki

  
  Title: Managing Director  

 

By: /s/ Robert McDonald  
 

Name:

Robert McDonald

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

BofA Securities, Inc.

 

As Agent

 

By: /s/ Hicham Hamdouch  
 

Name:

Hicham Hamdouch

  
  Title: Managing Director  

 

Bank of America, N.A.

 

As Forward Purchaser

 

By: /s/ Rohan Handa  
 

Name:

Rohan Handa

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

BTIG, LLC

 

As Agent

 

By: /s/ Mike Passaro  
 

Name:

Mike Passaro

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Capital One Securities, Inc.

 

As Agent

 

By: /s/ Michael Sleece  
 

Name:

Michael Sleece

  
  Title: Senior Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Credit Agricole Securities (USA) Inc.

 

As Agent

 

By: /s/ Jean-Marc Nguyen  
 

Name:

Jean-Marc Nguyen

  
  Title: Managing Director; Head of Investment Banking  

 

By: /s/ Douglas Cheng  
 

Name:

Douglas Cheng

  
  Title: Managing Director  

 

Crédit Agricole Corporate and Investment Bank

 

As Forward Purchaser

 

By: Credit Agricole Securities (USA) Inc., as agent

 

By: /s/ Jean-Marc Nguyen  
 

Name:

Jean-Marc Nguyen

  
  Title: Managing Director; Head of Investment Banking  

 

By: /s/ Douglas Cheng  
 

Name:

Douglas Cheng

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Goldman Sachs & Co. LLC

 

As Agent and Forward Purchaser

 

By: /s/ Ryan Cunn  
 

Name:

Ryan Cunn

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Jefferies LLC

 

As Agent and Forward Purchaser

 

By: /s/ Michael Magarro  
 

Name:

Michael Magarro

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Mizuho Securities USA LLC

 

As Agent

 

By: /s/ Ivana Rupcic-Hulin  
 

Name:

Ivana Rupcic-Hulin

  
  Title: Managing Director  

 

Mizuho Markets Americas LLC

 

As Forward Purchaser

 

By: /s/ Matthew E. Chiavaroli  
 

Name:

Matthew E. Chiavaroli

  
  Title: Authorized Signatory  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Morgan Stanley & Co. LLC

 

As Agent and Forward Purchaser

 

By: /s/ Ethan Woo  
 

Name

: Ethan Woo

  
  Title: Vice President  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Nomura Securities International, Inc.

 

As Agent (as forward seller)

 

By: /s/ Jason Eisenhauer  
 

Name:

Jason Eisenhauer

  
  Title: Managing Director  

 

Nomura Global Financial Products, Inc.

 

As Forward Purchaser

 

By: /s/ Jeffrey Petillo  
 

Name:

Jeffrey Petillo

  
  Title: Authorized Representative  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

RBC Capital Markets, LLC

 

As Agent

 

By: /s/ Asad Kazim  
 

Name:

Asad Kazim

  
  Title: Managing Director  

 

Royal Bank of Canada

 

As Forward Purchaser

 

By: /s/ Brian Ward  
 

Name:

Brian Ward

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Regions Securities LLC

 

As Agent and Forward Purchaser

 

By: /s/ Edward L. Armstrong  
 

Name:

Edward L. Armstrong

  
  Title: Managing Director - ECM  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Robert W. Baird & Co. Incorporated

 

As Agent and Forward Purchaser

 

By: /s/ Christopher Walter  
 

Name:

Christopher Walter

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Scotia Capital (USA) Inc.

 

As Agent

 

By: /s/ Tim Mann  
 

Name:

Tim Mann

  
  Title: Managing Director  

 

The Bank of Nova Scotia

 

As Forward Purchaser

 

By: /s/ Kshamta Kaushik  
 

Name:

Kshamta Kaushik

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

TD Securities (USA) LLC

 

As Agent

 

By: /s/ Brad Limpert  
 

Name:

Brad Limpert

  
  Title: Managing Director  

 

The Toronto-Dominion Bank

 

As Forward Purchaser

 

By: /s/ Vanessa Simonetti  
 

Name:

Vanessa Simonetti

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Truist Securities, Inc.

 

As Agent

 

By: /s/ Geoffrey Fennel  
 

Name:

Geoffrey Fennel

  
  Title: Director  

 

Truist Bank

 

As Forward Purchaser

 

By: /s/ J. West Riggs  
 

Name:

J. West Riggs

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Wells Fargo Securities, LLC

 

As Agent

 

By: /s/ Elizabeth Alvarez  
 

Name:

Elizabeth Alvarez

  
  Title: Managing Director  

 

Wells Fargo Bank, National Association

 

As Forward Purchaser

 

By: /s/ Elizabeth Alvarez  
 

Name:

Elizabeth Alvarez

  
  Title: Managing Director  

 

[Signature Page to Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement]

 

 

 

 

Annex 1

 

Healthpeak Properties, Inc.

 

Common Stock
($1.00 par value)

 

TERMS AGREEMENT

 

[●]

 

Ladies and Gentlemen:

 

Healthpeak Properties, Inc., a Maryland corporation (the “Company”), proposes, subject to the terms and conditions stated herein and in the At-the-Market Equity Offering Sales Agreement, dated February 17, 2023 (the “Sales Agreement”), among the Company, Healthpeak OP, LLC, a Maryland limited liability company (the “Operating Company”) and J.P. Morgan Securities LLC, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Nomura Securities International, Inc., RBC Capital Markets, LLC, Regions Securities LLC, Robert W. Baird & Co. Incorporated, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, each as sales agent, as principal (except in the case of Nomura Securities International, Inc.) and as forward seller (except in the case of BTIG, LLC) (in any such capacity, each, an “Agent”, and collectively, the “Agents”), and JPMorgan Chase Bank, National Association, Bank of America, N.A., The Bank of Nova Scotia, Barclays Bank PLC, BNP Paribas, Crédit Agricole Corporate and Investment Bank, Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, Nomura Global Financial Products, Inc., Regions Securities LLC, Robert W. Baird & Co. Incorporated, Royal Bank of Canada, The Toronto-Dominion Bank, Truist Bank and Wells Fargo Bank, National Association each as forward purchaser (in such capacity, each a “Forward Purchaser”, and collectively, the “Forward Purchasers”), to issue and sell to [●], as Agent, the securities specified in the Schedule hereto (the “Purchased Securities”) [, and solely for the purpose of covering over-allotments, to grant to the Agent the option to purchase the additional securities specified in the Schedule hereto (the “Additional Securities”)] 1.  Capitalized terms used herein and not defined have the respective meanings ascribed thereto in the Sales Agreement.

 

 

1   Include only if [●] has an over-allotment option.

 

 

 

 

[The Agent shall have the right to purchase from the Company all or a portion of the Additional Securities as may be necessary to cover over-allotments made in connection with the offering of the Purchased Securities, at the same purchase price per share to be paid by the Agent to the Company for the Purchased Securities; provided that the purchase price payable by the Agent for any Additional Securities shall be reduced by an amount per share equal to any dividends or distributions paid or payable by the Company on the Purchased Securities but not payable on such Additional Securities.  This option may be exercised by the Agent at any time (but not more than once) on or before the thirtieth day following the date hereof, by written notice to the Company.  Such notice shall set forth the aggregate number of shares of Additional Securities as to which the option is being exercised, and the date and time when the Additional Securities are to be delivered (such date and time being herein referred to as the “Option Closing Date”); provided, however, that the Option Closing Date shall not be earlier than the Time of Delivery (as set forth in the Schedule hereto) nor earlier than the second business day after the date on which the option shall have been exercised nor later than the fifth business day after the date on which the option shall have been exercised. Payment of the purchase price for the Additional Securities shall be made at the Option Closing Date in the same manner and at the same office as the payment for the Purchased Securities.  For purposes of clarity, the parties hereto agree that any Option Closing Date shall be a date on which Shares are delivered to the Agent pursuant to a Terms Agreement within the meaning of, and requiring the affirmation and deliverables described under, Sections 3((j), (k) and (l) of the Sales Agreement.]*

 

Each of the provisions of the Sales Agreement not specifically related to (a) the solicitation by the Agent, as agent of the Company, of offers to purchase securities or (b) the Confirmations, Confirmation Shares and related transactions is incorporated herein by reference in its entirety, and shall be deemed to be part of this Terms Agreement to the same extent as if such provisions had been set forth in full herein.  Each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Terms Agreement [and] [,] the Applicable Time [and any Option Closing Date]*, except that each representation and warranty in Section 1 of the Sales Agreement which makes reference to the Prospectus (as therein defined) shall be deemed to be a representation and warranty as of the date of the Sales Agreement in relation to the Prospectus, and also a representation and warranty as of the date of this Terms Agreement [and] [,] the Settlement Date [and any Option Closing Date]* in relation to the Prospectus as amended and supplemented to relate to the Purchased Securities.

 

An amendment to the Registration Statement (as defined in the Sales Agreement), or a supplement to the Prospectus, as the case may be, relating to the Purchased Securities [and the Additional Securities]*, in the form heretofore delivered to the Agent is now proposed to be filed with the Securities and Exchange Commission.

 

 

 

 

Subject to the terms and conditions set forth herein and in the Sales Agreement which are incorporated herein by reference, the Company agrees to issue and sell to the Agent and the latter agrees to purchase from the Company the number of shares of the Purchased Securities at the time and place and at the purchase price set forth in the Schedule hereto.

 

If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company and the Operating Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement between the Agent, the Company and the Operating Company in accordance with its terms.

 

[Signature Pages Follow]

 

 

 

 

THIS TERMS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

 

  Very truly yours,
   
  Healthpeak Properties, Inc.
   
  By  
    Name: Peter A. Scott
    Title: Chief Financial Officer
   
  Healthpeak OP, LLC
   
  By: Healthpeak Properties, Inc.,
  its Managing Member
   
  By:  
    Name: Peter A. Scott
    Title: Chief Financial Officer

 

Accepted as of the date hereof:

 

[●]

 

By:    
  Name:    
  Title:      

 

 

 

 EX-5.1 3 tm248304d1_ex5-1.htm EXHIBIT-5.1

 

Exhibit 5.1

 

 

 

March 11, 2024

 

Healthpeak Properties, Inc.

Healthpeak OP, LLC

4600 South Syracuse Street

Suite 500

Denver, Colorado 80237

 

Re:Healthpeak Properties, Inc., a Maryland corporation (the “Company”) – Registration of shares of common stock, par value one dollar ($1.00) per share (the “Common Stock”), of the Company having an aggregate gross sales price of up to $1,500,000,000 (the “Shares”) to be sold in an at-the-market offering (the “Offering”) pursuant to a Registration Statement on Form S-3 (File Nos. 333-276954 and 333-276954-01) relating to an indeterminate aggregate initial offering price or number of (i) the Company’s shares of Common Stock, shares of preferred stock, par value $1.00 per share, depositary shares, debt securities, warrants and guarantees of debt securities of the Operating Company (as defined herein) and/or debt securities of the Company’s existing and future subsidiaries, and (ii) the Operating Company’s debt securities and guarantees of debt securities of the Company and/or debt securities of the Operating Company’s existing and future subsidiaries, filed with the Securities and Exchange Commission (the “Commission”) on February 8, 2024 (the “Registration Statement”)

 

Ladies and Gentlemen:

 

We have acted as Maryland corporate counsel to the Company in connection with the registration of the Shares under the Securities Act of 1933, as amended (the “Act”), by the Company pursuant to the Registration Statement. We understand that, as of the date of the Prospectus Supplement (as defined herein), the Company has not sold any Shares pursuant to the Agreement (as defined herein), and, accordingly, Shares having an aggregate gross sales price of up to $1,500,000,000 remain available for offer and sale pursuant to the Prospectus Supplement. You have requested our opinion with respect to the matters set forth below.

 

In our capacity as Maryland corporate counsel to the Company and for the purposes of this opinion, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (collectively, the “Documents”):

 

(i)the corporate charter of the Company (the “Charter”), consisting of Articles of Incorporation filed with the State Department of Assessments and Taxation of Maryland (the "Department") on December 13, 2022, Articles of Amendment and Restatement filed with the Department on February 9, 2023, Articles of Amendment filed with the Department on February 9, 2023 and Articles of Amendment filed with the Department on February 29, 2024;

 

 

 

 

 

BALLARD SPAHR LLP

 

Healthpeak Properties, Inc.

March 11, 2024

Page 2

 

(ii)the Amended and Restated Bylaws of the Company, dated as of February 10, 2023, as amended (the “Bylaws”);

 

(iii)resolutions adopted by the Board of Directors of the Company (the “Board”) on or as of February 10, 2023 and February 1, 2024 (collectively, the “Initial Board Resolutions”) and February 10, 2023, April 27, 2023 and January 31, 2024 (the “ATM Sales Limit Board Resolutions” and together with the Initial Board Resolutions, collectively, the “Board Resolutions”), and the form of resolutions (the “Subsequent Resolutions”, and together with the Board Resolutions, collectively, the “Directors’ Resolutions”) to be adopted from time to time by the Board;

 

(iv)a fully executed copy of the At-The-Market Equity Offering Sales Agreement, dated as of February 17, 2023, as amended by Amendment No. 1 to At-The-Market Equity Offering Sales Agreement, dated as of March 11, 2024 (collectively, the “Agreement”), by and between the Company, Healthpeak OP, LLC, a Maryland limited liability company of which the Company is the managing member (the “Operating Company”), and J.P. Morgan Securities LLC, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Nomura Securities International, Inc., RBC Capital Markets, LLC, Regions Securities LLC, Robert W. Baird & Co. Incorporated, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, each as sales agent and principal (except in the case of Nomura Securities International, Inc.) and forward seller (except in the case of BTIG, LLC and Capital One Securities, Inc.), and JPMorgan Chase Bank, National Association, Bank of America, N.A., The Bank of Nova Scotia, Barclays Bank PLC, BNP Paribas, Crédit Agricole Corporate and Investment Bank, Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, Nomura Global Financial Products, Inc., Regions Securities LLC, Robert W. Baird & Co. Incorporated, Royal Bank of Canada, The Toronto-Dominion Bank, Truist Bank and Wells Fargo Bank, National Association, each as forward purchaser;

 

(v)a certificate of one or more officers of the Company, dated as of a recent date (the “Officers’ Certificate”), to the effect that, among other things, the copies of the Charter, the Bylaws, the Organizational Minutes and the Board Resolutions are true, correct and complete, have not been rescinded or modified and are in full force and effect on the date of the Officers’ Certificate, and certifying as to the manner of adoption of the Board Resolutions, the authorization for issuance of the Shares, the form of the Subsequent Resolutions, and the form, approval, execution and delivery of the Agreement;

 

(vi)the Registration Statement and the related base prospectus dated February 8, 2024, and the prospectus supplement dated March 11, 2024 relating to the Shares (the “Prospectus Supplement”), included therein, in substantially the form filed or to be filed with the Commission pursuant to the Act;

 

 

 

 

BALLARD SPAHR LLP

 

Healthpeak Properties, Inc.

March 11, 2024

Page 3

 

(vii)a status certificate of the Department, dated as of a recent date, to the effect that the Company is duly incorporated and existing under the laws of the State of Maryland; and

 

(viii)such other laws, records, documents, certificates, opinions and instruments as we have deemed necessary to render this opinion, subject to the limitations, assumptions and qualifications noted below.

 

In reaching the opinions set forth below, we have assumed the following:

 

(a)each person executing any instrument, document or agreement on behalf of any party (other than the Company and the Operating Company) is duly authorized to do so;

 

(b)each natural person executing any instrument, document or agreement is legally competent to do so;

 

(c)all Documents submitted to us as originals are authentic; the form and content of all Documents submitted to us as unexecuted drafts do not, and will not, differ in any respect relevant to this opinion from the form and content of such documents as executed and delivered; all Documents submitted to us as certified or photostatic copies conform to the original documents; all signatures on all Documents are genuine; all public records reviewed or relied upon by us or on our behalf are true and complete; all representations, warranties, statements and information contained in the Documents are true and complete; there has been no modification of, or amendment to, any of the Documents, and there has been no waiver of any provision of any of the Documents by action or omission of the parties or otherwise;

 

(d)all certificates submitted to us, including but not limited to the Officers’ Certificate, are true, correct and complete both when made and as of the date hereof;

 

(e)none of the Shares will be issued or transferred in violation of the provisions of Article V of the Charter relating to restrictions on ownership and transfer of stock or the provisions of Article V of the Charter relating to business combinations;

 

(f)none of the Shares will be issued and sold to an Interested Stockholder of the Company or an Affiliate thereof, all as defined in Subtitle 6 of Title 3 of the Maryland General Corporation Law (the “MGCL”), in violation of Section 3-602 of the MGCL;

 

(g)the Company has not, and is not required to be, registered under the Investment Company Act of 1940;

 

(h)prior to issuance and sale of any of the Shares (other than the shares of Common Stock authorized for issuance and sale as provided in, and in accordance with, the ATM Sales Limit Board Resolutions), resolutions in the form of the Subsequent Resolutions setting forth, with respect to such Shares, the maximum aggregate gross sales price of such Shares to be issued and sold, the minimum gross sales price per share and the minimum price to be received by the Company per share (net of any discounts provided or commissions paid by the Company in connection with the offering of such Shares) will have been duly adopted at a duly convened meeting of the members of the Board or by unanimous consent of the members of the Board given in writing or by electronic transmission;

 

 

 

 

BALLARD SPAHR LLP

 

Healthpeak Properties, Inc.

March 11, 2024

Page 4

 

(i)the aggregate gross sales price of all of the Shares sold pursuant to the Agreement will not exceed $1,500,000,000; the aggregate gross sales price of all of the Shares sold pursuant to the Agreement during each approximately three month period between the regular quarterly meetings of the Board (or such other period of time as may be determined by the Board and set forth in the Directors’ Resolutions) will not exceed $500,000,000 (or such greater or lesser limit as may be determined by the Board and set forth in the Directors’ Resolutions); and the aggregate number of Shares issued and sold pursuant to the Agreement will not exceed the maximum aggregate number authorized for issuance and sale in the Directors' Resolutions;

 

(j)the consideration per Share to be received by the Company for each Share issued and sold pursuant to the Agreement will be determined in accordance with, and will not be less than the applicable minimum consideration per share set forth in, the Directors' Resolutions; and

 

(k)upon each issuance of any of the Shares subsequent to the date hereof, the total number of shares of Common Stock of the Company issued and outstanding, after giving effect to such issuance of such Shares, will not exceed the total number of shares of Common Stock that the Company is authorized to issue under the Charter.

 

Based on the foregoing, and subject to the assumptions and qualifications set forth herein, it is our opinion that, as of the date of this letter:

 

1.The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Maryland.

 

2.The Shares to be issued in the Offering have been generally authorized for issuance by the Company pursuant to the Agreement, and when such Shares are issued and delivered pursuant to due authorization by the Board subsequent to the date hereof, in exchange for payment of the consideration therefor, as provided in, and in accordance with the terms of, the Agreement and the Directors’ Resolutions, such Shares will be duly authorized, validly issued, fully paid and nonassessable.

 

The foregoing opinion is limited to the substantive laws of the State of Maryland, and we do not express any opinion herein concerning any other law. We express no opinion as to the applicability or effect of any federal or state securities laws, including the securities laws of the State of Maryland, or as to federal or state laws regarding fraudulent transfers. To the extent that any matter as to which our opinion is expressed herein would be governed by the laws of any jurisdiction other than the State of Maryland, we do not express any opinion on such matter.

 

 

 

 

BALLARD SPAHR LLP

 

Healthpeak Properties, Inc.

March 11, 2024

Page 5

 

This opinion letter is issued as of the date hereof and is necessarily limited to laws now in effect and facts and circumstances presently existing and brought to our attention. We assume no obligation to supplement this opinion letter if any applicable laws change after the date hereof, or if we become aware of any facts or circumstances that now exist or that occur or arise in the future and may change the opinions expressed herein after the date hereof.

 

We consent to the incorporation by reference of this opinion in the Registration Statement and further consent to the filing of this opinion as an exhibit to the applications to securities commissioners for the various states of the United States for registration of the Shares. We also consent to the identification of our firm in the section of the Registration Statement entitled “Legal Matters”. In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the Act.

 

  Very truly yours,
   
  /s/ Ballard Spahr LLP

 

 

 

 EX-101.SCH 4 hcp-20240311.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 hcp-20240311_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 hcp-20240311_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 tm248304d1_ex5-1img001.jpg GRAPHIC begin 644 tm248304d1_ex5-1img001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#T;Q9\3+;P M6!)K.A:O';/,T,,\8@=92,\@"7(! SR ?:H_#GQ0@\6632-1DN='U)'"&VU*+RSD]/F!*]QU/.1BNX!).*^9_VCHH4\::9)&%$KV \ MS'4X=L$_K^5>Q?"1]1;X9:.=5\T7.Q\>=G>4WMLSG_9QCVQ0!V]%,DFBA&9) M40'^\P%.5U90RL"IY!!XH P/%7BC_A%;!]0FTR\NK**,R3RVWE'R@/4/(I/X M US'@CXL6GCKQ1+IFGVD\,$5F]PS7$85BP=% &UV&/F/;TK6^*G/PO\ $/\ MUZ'^8KQ/]G'GQ_J.?^@6_P#Z-BH ]8\7_%JS\%W:VVJZ+JD;R[C ZK"ZR*#C M<,2Y Z=0#[5TG@GQ*?%OA2TUORO*%RTFU=N,*LC*,C)YPOK7BG[2G&MZ!C_G MWE_]"%>F?!/_ ))+HO\ VV_]'/0!Z!13))HHAF21$'JS 4Y75U#*P(/0@T + M11D>M,,L8D\LR+OQNVYYQZXH ?14,-W;7#,L-Q%(R_>"."1]<5(\L<2[I'5% M]6.!0!QGBWXBP>"X&N=6T/519^>($N8A RR,02,#S0W13U Z59\ ^-H?'>D7 M>IVT$D,$5T8$65 K$!%;)PS#JWK7&?M$LK_#FR92&!U.,@@YS^ZEIO[.7_(@ M:A_V$Y/_ $5'0![">EN+>QD\VYU6[_ ./6PMH]\LO.,XR !P>2 M0.#Z5T9Z5\U1>+[/1/VB]5U/76(MEFEM%E;+>0 JL!Z8&#CLQ- 'MJ:MXFM MD2ZOM'26W/+PV>&FC!]07P<>BDGTS3]+\=:%K>NIH^FW?VB[\F265!&RF'8R MJ5<-@JV6Z8SPF#0! M+12!E(!# @^]&1ZB@!:0G IBW$#OL6:-G_NA@33^#QP: /+_ !/\:K#PM>-I MVH:'JUMJ!C$BI)'"ZX.<'*3'TKT;2[MK_2;*\90IN($E( QC''1/">D,[!5%C#DDXQ\@H UZ*:LB.H9'5E/0@Y%+D>HH M 6BHFN;=(VD:>,(APS%QA3Z$TZ*:*>,212)(AY#(P(- 'B_[27_(JZ/_ -?Q M_P#0#67\!(-=F\+ZL=)O]/M5^V8875D\Q+;!R"LB8'X&M3]I+_D5='_Z_3_Z M :7]F[_D4]8_Z_A_Z+6@#D/%;IX2^(POO'VD'7IYPL\-S#<&*+:IP (MO\./ MND^F$-X; MC 'GXN"?4+^[_KG\C7/?#WQ/JG@7X7:_K<<19+J]AMK$2K0:(3'I*7*M+I^,]&O\ 6]?UO4KJ1;HV M\<$=RT*)A%8MB,KR=WTXZ5XM\684M_BAKD,9@?\ 7O+_ .A"N[^&5Q?6GP#M[G3(?/OX MK:Z>WBP3OD$DA48'7)QQWKA/VE?^0WH'_7O+_P"A"MO0/%TW@K]G'3=4M8U> M[9Y(8 XRN]II.3] "?J!0 OPC;4_%6IZU)XQT"*[DX<7M_:?.K$X,2AA@+CG M:H 'XBN#U[Q!=_#'XOZJF@,T&G1SHTEB&_=2(R*S+CH.IP>HKT'X-ZGK'CD: MOJ7B#6]0N#!(D<4,4[01C())Q'M]AZ"O(OB[ EM\4=;AC+E$>, O(SL?W29R MS$D_B: /I+XDZ387G@C6=3FMPUW;Z=*T,N2&0A21C!]:\,^"=G=:[KNM:<+A MT2>P+2R;R"^&&U"1SM+,"?4 CH37O_C[_DF/B#_L&3?^BS7BG[-O_(V:Q_UX MC_T-: &^!O"'BKX>^(K_ ,2ZQ:M9Z=IEK,UP%=<70V?+&F#SEBIST&/PI/A] M=S?%CXH2S^*3]LM;:UDN(K-B?)3#JJKMZ$#=WZXYS7L_Q5LYK[X8:_#;JS2? M9O,PO)(5@S?H#7B/[.C ?$&_!."=,DQ_W\CH Z;X[^'K?0O!=K_9*):Z=-J* MF:T3.P2^6^UT'1>-P('!.#USG8_9R_Y$#4/^PG)_Z*CIW[1C ?#ZR4D9.IQX M'_;*2F_LY?\ (@:A_P!A.3_T5'0![ >E>$?%;X-:CK6L77B+PZR32S#?<6;M MAF?IE#TY')!([XZXKW=AD5YYX#\51W?BGQ7X:N;E/M%IJN M&R3_ +U 'RQ=:5K>@W*M=65_I\R-\K21/$0?8X'Z5ZS\*/BSK#^(++P[K]T; MZRNV\B*:8;I8W/W/FZD$\(?!%GI_[0FA:?H4(B@F>#4)($&%A"NQ<#T&(\X_VL>E &-\=K"UT/QE9V M6GQ?9[5[!)'BC8A2V]P3R?0"O9?"'@W3-9\#:'<^(;.WU*YDTV%$\Y-RPQ;! MM5%)(4XQEAR3DYZ >1?M&?\ )0+#_L&I_P"C)*^@/ S!O 'APJ01_9EL./\ MKDM 'A?AWQA=$B>19W#?ZN0+_ XQQD9R?2O(_'%K-J'QKU*TM06FGU-8 MX]O7<2H%=Y\6?B=XBLO&TGAO1;TZ=!;F-))HP-\C.JMR3T W8XQT)R>* .J^ M)GA?1A\*;G4TT6RT_4K:"&9'MH%C>)]RY7( ./F(IGP%\7ZKXET34;+5;AKF M33FB$>:T_BAHMOI_PHUEA=7\TD<"#?/?3/O.] 25+;>? MI7&_LS?ZOQ/];7_VK0!R/[07_)2Q_P!>,7\VKV2Q\"VOBOP1IK>)WDNY38H; M>*.5XXK4%!MPJD;F QEFSDYQ@<5XW^T%_P E+'_7C%_-J^E/#W_(H:5_UX0_ M^BQ0!\T?!#Q3J.F>.K+1HIB=.U!V6:!N1N",58>AR!^''TZ[]H;3K32K;2;F MQB,$UY/,;AXV(\PX4\\^I->:_"/_ )*IH'_7=O\ T!J]4_:6_P"07X>_Z[3? M^@I0!SOA_P *:QXN^!4B62F::VO&-K;;\!U#!G;!X+DG ] I ^\<]W\%O!OB MOPQ!++K-T;>PF1]FF,VYDD+)B0XX'"D8]ZO? /GX76__ %]3?SKT[ ':@#A/ M'_P\N?']I!:7>L16L%O.9HO*LR6Y!&"3)@\'T%-\#?#R]\!:9=6.G:W;SK<2 M^:6N+$DJ< <8E''%=]10!YCJ/P\ M!7-W%IWB6UGTVY(=H;BQ8D,.-PQ(,''&<\X'%8WBOX!1Z_J[:G:Z_-%<3G== M&XA$GF.>KC!7;_NXQZ8Z5[/10!QVH^#=0U3PK?:+\#?!^3P)K4VJ6&O)/-+;FW*SV1VA2RMGB0<_*/UKU*B@#S3QY\ M*9_']W9W&H:[';M:HR(+>R.""03G,A]*NV7PRBC^'C>"]0OUN]/",(Y5M_+E M1S(7#9+,."?2N^HH \O\$?"_6O 6HWC:7XCMIK"[ \R&YL"2"N=I&V0<\D9Z M<].!65XN^ L/B+4GU.UUZ:&]F.ZY:XA$BRL>K#!&WZ=.!C%>RT4 $-3N M_#-_H]QKL!?A)-X"U&ZO=/UZ.XD MN(?)99[(D 9!R,2#TKT^B@!@1C& Y#-CYL# /XUS7?&UG=:5H>J7L"V"1F2 MWLY'4-O#-#M9X9H9X-.MXY$EC9"K"-0001U!% '.>#_ M (6VGAK7;KQ!?Z@^K:UVU. M33[YD59,Q"1)-HPI/((.,#.3T%>I44 <;J'@W4/$?AL:-XEU:&XA,>U_L=N8 MB[A<*S$NV<'#8P!D#MQ7+^#_ (,W/AB>\@E\1&XTNZDA>:V2UV--Y;;E#-N. M!G@@#YAQQ7K5% 'D_C3X+R>-]>_M>^\0+!-Y2Q;(++Y<*3CK(?6N_L=.U'3] M$AL?M]JS01)$DIM6 "J,NB\!AY2[I'#/D?*IV@ ]RP]: +'@+PV?".C0Z+9Z[9WUNDCR'_1\2-NY. M")"!^5=N.E>5^ ?!M[+;:-J6IF>R?2KR^DAMF@, GRAPHIC 8 tm248304d1_ex5-1img002.jpg GRAPHIC begin 644 tm248304d1_ex5-1img002.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#WBXNH[;;Y MBS'=G'EPO)^>T'%,BOX9I BK< GN]O(@_,J!5JDQ0!6DU""*0HR7)([K;2,/ MP(7!IRWD3P-,%G"J<$&!PWX*1D_@*L8I,4 5!J=N2!Y=WS_TZ2__ !-23WL5 MNX5UG)(S^[@=Q^:@U8Q10!7AO8IRP19EQ_ST@=/RW 9J+^U;?_GG=_\ @'+_ M /$U!I@)@H[&%PWX*1D_E5C%)@4 4_[4M_ M^>=W_P" 0. MG_H0&:B_M2W_ .>=W_X!R_\ Q-7<44 5Y+V&.%9668JW0+ [,/JH&1^(IL6H M0S2B-4N Q[O;2*/S*@59Q1B@"K)J,$4C(R7)([I:R,/P(7!J1+N.2!IE68*O M4-"X;\%(R?P%3 48H IC5+16[ .LS$_\\X'0.@_-@*B_M2W!_U=W_X!R_\ Q-7,4H&* *[W MD20),5G*MT"P.6_%0,C\138M0@ED"*ER">A>VD4?F5P*LXHQ0!5DU&"*0HR7 M)([I;2,/P(7!IZ7D3P-,%FVJ<$&!PWX*1D_E4^*",C% %0:I;D@>7=_C9R__ M !-2SW<5N0'68D_\\X'?_P!!!Q4V.*7% %>"]BN&94692!D^9 Z#\V S41U2 MW!(,=WD>EI+_ /$U>*+^#X9IXFCBM_M1LX[AHV!*9;&0.<]_6NLF#&)P@!8J0 3@9^M%[V?X:KX866W%R+1+8REFV?+CYNF>W2@#;U>]N;'["T(C9);J."0.#G:QQ MD8/7ZU8U&:>UTVZGMXC-/%"[QQC^-@"0/Q-5M6L[F^ALQ$(@T5S'.X=R!\IS M@<<_I5R[6X>V86LB1S<%2XR.""0?J,B@"CH.IPZQ9B^M+Y;NUE^X=FUD/.Y2 M.Q''!Y'O3]>U9=%T6YU QF4Q ;8P<;V)"J,]LDCFJZZ7<6T^I7EDMK!=W<2* MJX)CWKNP[8P23N /?"BK6JZ5%K6C3Z==,RK,N"\?!5@00P^A - #?)U5H(Y/ MMD23C:7C$>8^OS '[W3C.??%3KJ%JU[]C$ZFXVD[/7&,^V1D<>XJO''J\=E' M \]M)<+A6N2I&X \GR^@)'OC/Y55CTJ^_MJVOI9862$S@*N5^60@J<8QD8P> MN>O'2@"#P[KRRV-I#?W,DE[<2W(C_=$[UCE8=5&!@ >E:B:YISPQ3"X*QRG" MEXV7'.!G(^7)&.<9-8J^%K@Z%;6INE@OK6\>YAN(B2%#NQ8= 3E793^=6SH; MQZL\T4-E+9RQ1QF*X3+0E,X*8!!&"...1G- %JX\3:-;"]WWT;-91O)<(F69 M%0 MD#TW#BKD%ZEY8BZMA(RL,H'1HR3Z88 BL>ZT&>]TGQ%8N\47]J"18W4E MM@:)8^1@=-N>*UTCN!IXCW(DXBV@CYE#8QGMD4 86@^(#J.F-J-Q>*I@C(O[ M0QD/:S#&5P.<#YNH.>"*O2>*M&M]/M[ZYO/L]O<9\HS1NA;"EC@$9Z _7M4, MV@->:C+?2&*WFEL9+200Y(D+$?,V0,[<' ]S3'T2ZD?PX2T'_$KD+2_,?G'D MM%QQZMGGTH UQJEDUR+<7"F0\8&<9QG;GINQSCKCFJ]QXATVWT^ZOFN"8+9 M\A5&)*GH5&/F!P<$9!P:RK3PS<0+J%I(]I+!:?,NGPW_8_3> MC(?3D, 16;KU]?Z=IMU>VH@80+O$<@),OJH((VD]!UY-6(VOO[15)/+%KY&6 M 4Y$F>,-W&,\8&,>]5M2@U6>]0V\5C):H P2>1E/F9X8@*<@=AZ\^F !=4DU M>W6:>UN+-8U $<3V[.SL> -WF*!EB!TJ.;6%:TU&U29UU"TMB972%@B/L#<% M@5_B!QD_C5Y[:6>:T\]@4A!=MO >3H./0P]Z;INAW5GJ>G7,C0[+;3/L3A&.2V4.1QT^3]:M MW5A-/K]I>[(&MX;>:)@['<2[1G(&,<>7Z]_:@"@]_=Q>(]$@-]YEK<65Q)+A M5"N4\O:_3(X<\9Q6S::I97N\07"L44,<@CY3T89Z@X.".#61K?AZ75+ZW:.2 M.&VCLKFT."=P\T( 5 &.-GKW]N8]0\,2ZSYC7ER()'TV2PW6V:Z&UC:*UBC8*&5 M#MZ9Q0!-1110 4444 %%%% !1110!4U+4(=+LI;RX#^3$I9RBEB!]!26NH07 M4\UNGF)/ %,DAK-\:.B>$-3W.$)MV R><^WK6;!-<:?X@ MOYDN7O[.2P\Z6]= [Q,C$)& @ 8$,[8'.<^M '2ZC?1Z=:BXDC=U\V./"8R" M[!0>2.,D5-+*D$+RR,%1%+,WH!R:X^;43/I-^)KDR)'J%H83+M#;"8')XXQD MO],'TJXEQ;6'2*\B>07DJ*5#_ "[4R !RV,]<8YH M ZW%4DU2U;5WTO>1=K")]A7&Y,XR#WYXHMK^%IQ8/,TEW' DCGRBH8'(W#MU M!X!XR/45S^ON(M8.JV2">\TR.,R1IR[0,7$B@>N-K8]5'K0!T#ZI;)JR:7O+ M7;Q&;8%)VH#C<3T SQ4$.NVUR+@PQ7+);R-%(P@8@.O48ZG\*SK9]OBRV>YV M1W5Q9S.T>1E!OBVK[G _,-BF>&;ZUB36=\\8(U.X;&X9(SU [T =#9W=M?VD M=W:3+-!*-R2(96C2YO9[F&%A@QQNY(!'8GKCMFJFGW ML3Z_?*-;$]L8PA@:8%EE4MO88Y5<;1V&1^8!U&!1CBN/CO$;P/:33:O)#<2P M@>:;G!,Q7C+'I@\XZ59EO9FO-'26_)T][>0RW]1(=DCYZ_( 2.^>F<5T4=Y>3S M1-;0VTU@R9^TBX(+<'[JA2",]]U %DW< NUM1*IF(W>6.2%]3CH/ M'9KR);&::")KC4#(VJ$H5EA903\QST! 0# X(Q4FC+-JGA1)Y=9O[_G-]Y33B:YPSJI)PO W<8Z= MB?2NO@F2>!)8FW(PR&'>@!^!2XHHH 3 I:** "BBB@ HHHH **** "BBB@!" M,T;1G..:S=9N]0LX/.LK>"6-$=Y3+*4("C(Q@'.>:PYO%.HVWA_3]4ELK8+> MRP*BK,[;5E Y.%SD$] * .NVCWHQ[FN=M-=OYKS2(9;6W5+^.65F65LHJD$8 M!4=0R\'&.16W=745G;27$S;8XQDGU]AZGL!0!/M&<]Z3:/>L'_A)6F\.V&LV MMF9(;PQ!8WDV,OF,%7L>[#-2'7R+SR_LKFV6Y%H\X<<2G&/E_NY(&?7MCF@# M;V^YHVCU/YUEW.K^3K%MIB1[YID\SYI%4! <$C/+$>@'Y50F\0W;C6K:*S6W MN[*V\Z*2>53$20Q4.0?E/RY(]".>: -];>)9WG"_O'4*6SV'0?K3]@KG_"NJ MW&J6=S+-)*WERA MQ&$E7Y%)#* !U/!'4$5!/XKEET=+RQLRSW-P+:V1G!)8 MYR64?=VA6.W.>,<4 =1M%&T5R]EXB:2V5+,7&I7.96E$P6!H_+8*RXQP]3R>*5*2SVMG+-:P6\=S/+N"E$==PPI^\0O)''XF@#HJ3:/>A3D>M+0 FT M4;12T4 )M &*, ]:6B@!-HJ"ZLX[N)(I"PC5UTF+>5,A1MIP<&K &!BEHH **** "BBB@ HHHH **** "BBB@ HHHH MANK9;NUEMW9E21"C%3S@C!K-E\-V=AD"[=^WIG'^/7FM3BES0!CC1%2XL5C<_9[29YQYC,\ MC.P<8R>@PY_0=J:/#%BRW23R7-Q#=+(LL4LQ*G?][C]/;M6SQ[4N1ZT 8[>' M+(^4Q>Y+Q7"W._SV!=U7: Q'WA@#@\5%#X:MVCN3=%C-<7WVXM$Q'ER *JE? MHJC/J2>.<5N9'J*"RJ,D@#U)H QG\+Z<]NL6)DQYFYXYF5W\PY?+ Y.3S[=L M4MQX8TVYF\QDE0&)(72.5E21%.55E!PHI: 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &!XQO[K2_#TUY9S&* M='C5>%(.Z1%/W@>Q-9>MZ]K.DZ; ;>UDN;R)FN+J,JK,+=7P1\N "1R#C^$U MU\UO#< ":)) .@=0::;2V8L3!$2R[6)0HC[#<1*9 MR$4_9$8C$_(Y7M@^N>@-;]_JEKI.F&[NIU$8PJN[!=['H,\#G\N_2K/V&T 8 M"UAPR[2-@Y'I4GD1>6(_+38O1<<#\* ./MO$]SJ&A:5?P7%L);F_6VG6,B15 M!#@ _K3H/$MV;JV>>:V"37<\$UKMP]O'&'^^_IVAV. MGV$-FL*2I$696E16.68D]O?]!5\00AV<1KN889LF: .;BUV:\UR2.&[MD ML7LC&P I(RN.X.>:Q[_6)-3T*W@%W8WMU+?8BC'RQ7$8W,@D MY.P,J$CW XYKLDTNV6]>X90Y:,0HC*-L:=2JC'0GD^N!Z"IEL;18VC6VA",< MLH08/U% '*RZW-:>$+,:9*LMY%9V\TZRC?)# 5YD*!@6^Z>,\X/7O7;599_$ M6+R(7<-I<6]M#&C;=S2(&,X3!W#DXYX"MC/-=;?:=%?0-"S/&KX63R\ N@_@ M)QT//2K @B$BR"--ZC:&QR!Z9H Y-M?U-9[Z*X>&WDCO(X ICRL$+L=LS-N^ M8,!@=,-P1Q6UH-[+>PW7FRQ3B&X:)+B)=JR* #ZGD$E3SC*GIT%JUT^*W:X9 MB9I+A]TCR 988P!P.@ Z?4]ZMI&D:A4554= HP* '4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% "$XHW#'>L?Q+I U72V\J- M3>VY$UJQQD2(RN!GL"5 /L:HZ1X>>SU"ZDO$A>"1C<(@4$++* )%&>PV\'T< M^E '3;A[TF\&N*T_PW?0W-K]JMH7BC#6##((-JC;XW([L=H4CWJQK?AN6[U" MY%K;1"WN8DN'<$*1QBL T\@2>0HZA7D,@9U&2#Z\D<\P,&_5#>6Z'RRCC[.B89ZV M[?.B63 .<9&:L;@:X^'2;R""X2/32HFT>.W(5HQNF&X$'YNOS#GI[U;-G=V_ MARWL[72]LJQQ23(&10[*Z;T.#R64-ST]30!T@<$9Z XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Mar. 11, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 11, 2024
Entity File Number 001-08895
Entity Registrant Name Healthpeak Properties, Inc.
Entity Central Index Key 0000765880
Entity Tax Identification Number 33-0091377
Entity Incorporation, State or Country Code MD
Entity Address, Address Line One 4600 South Syracuse Street
Entity Address, Address Line Two Suite 500
Entity Address, City or Town Denver
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80237
City Area Code 720
Local Phone Number 428-5050
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $1.00 par value
Trading Symbol DOC
Security Exchange Name NYSE
Entity Emerging Growth Company false
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://hcpi.com/role/Cover Cover Cover 1 false false All Reports Book All Reports hcp-20240311.xsd hcp-20240311_lab.xml hcp-20240311_pre.xml tm248304d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm248304d1_8k.htm": { "nsprefix": "hcp", "nsuri": "http://hcpi.com/20240311", "dts": { "schema": { "local": [ "hcp-20240311.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "hcp-20240311_lab.xml" ] }, "presentationLink": { "local": [ "hcp-20240311_pre.xml" ] }, "inline": { "local": [ "tm248304d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://hcpi.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-11", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm248304d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-11", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm248304d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://hcpi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 18 0001104659-24-032999-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-032999-xbrl.zip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end XML 19 tm248304d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000765880 2024-03-11 2024-03-11 iso4217:USD shares iso4217:USD shares false 0000765880 8-K 2024-03-11 Healthpeak Properties, Inc. MD 001-08895 33-0091377 4600 South Syracuse Street Suite 500 Denver CO 80237 720 428-5050 false false false false Common stock, $1.00 par value DOC NYSE false